Markets

Edesa Biotech Announces Pricing of $25.0 Million Public Offering

1 source ·1 article ·2h ago

TORONTO, Aug. 19, 2026 (GLOBE NEWSWIRE) — Edesa Biotech, Inc. (Nasdaq: EDSA) (the “Company” or “Edesa”), a clinical-stage biopharmaceutical company focused on developing host-directed therapeutics for immuno-inflammatory diseases, today ann…

Covered by 1 outlet

Financialpost 1

All coverage · 1 article

Financial Post ·2h ago

Edesa Biotech Announces Pricing of $25.0 Million Public Offering

Edesa Biotech Announces Pricing of $25.0 Million Public Offering →

Edesa Biotech Announces Pricing of $25.0 Million Public Offering